Dr. Laura Oliphant is a General Partner with Spirit Ventures, a new venture capital firm focusing on funding key enabling technologies. She is an experienced CEO, Board Member, and Investor who was an Investment Director in Intel Capital from 2001 until 2016. At Intel, she was awarded the company’s highest award, the Intel Achievement Award, for the strategic impact of her contributions. Subsequently, she was the CEO of Translarity, an investor-backed, semiconductor test startup. She currently holds board seats at Novelda AS and Numascale AS, both based in Oslo, Norway.
Before Intel Capital, Laura was a Supply Chain Program Manager in Intel’s Technology and Manufacturing Group. Dr. Oliphant was a key coordinator for Intel’s transition to the 300 mm wafer size in their factories, a project that added to Intel’s gross margin. She was also the co-chairperson of the SEMATECH Metrology and Yield Management Advisory Group, and part of the International Technology Roadmap for Semiconductors committee. She is currently on the board of advisors for the UC Berkeley Skydeck Accelerator and has served on the Lawrence Berkeley Lab Innovation Grant Committee.
Dr. Oliphant received her PhD in Chemical Engineering from the University of California, Berkeley.